3 Key Takeaways
Plain English Summary- 01Core Finding
A timed clodronate liposome regimen that preferentially reduced recipient-retained GFP + KRMs decreased the cortical accumulation of RFP + cells, albuminuria, and histologic kidney injury in NTSN mice.
- 02Study Evidence
Tested in a in vivo animal model (preclinical discovery) at the preclinical stage.
- 03Practical Meaning
Early laboratory or animal model findings — human trials are still needed to confirm safety and benefit.
What This Means for You
These findings indicate that ontogenically distinct and spatially segregated macrophage populations cooperate during early cGN and support further investigation of the CCR2 axis as a therapeutic target for macrophage-mediated kidney injury in cGN.
The Discovery
To explore this, we used single-cell RNA sequencing (scRNA-seq), reporter-based bone marrow chimeras, timed clodronate liposome treatment, and chemokine blockade to define the spatiotemporal dynamics and functional roles of macrophage populations in nephrotoxic serum nephritis (NTSN), a model of cGN. scRNA-seq of total kidney and CD45 + immune cells revealed that proliferating macrophages and infiltrating monocytes expanded sharply by day five and declined by day ten, indicating that local proliferation, in addition to monocyte recruitment, contributes substantially to early macrophage accumulation in NTSN. Two major KRM subpopulations were distinguished by high Ccr2 or Mrc1 expression, consistent with bone marrow and embryonically seeded, self-renewing KRM population, respectively. In Cx3cr1-GFP recipient mice reconstituted with Ccr2-RFP + donor bone marrow, embryonic-derived GFP + KRMs were enriched in the outer medulla and corticomedullary region, whereas donor-derived RFP + monocytes/macrophages preferentially accumulated in the cortex, including within and around the inflamed glomeruli. A timed clodronate liposome regimen that preferentially reduced recipient-retained GFP + KRMs decreased the cortical accumulation of RFP + cells, albuminuria, and histologic kidney injury in NTSN mice. Cell-cell communication analysis identified macrophage-associated CCL12 expression, a murine ortholog of human CCL2, as a candidate mediator of cortical CCR2 + monocyte recruitment. CCL12 neutralization reduced cortical monocyte accumulation and ameliorated kidney damage in NTSN mice.
How It Works, Simply
This nephrology research focuses on immune response. Researchers evaluated it using an in vivo animal model (Preclinical discovery) at the preclinical stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
A timed clodronate liposome regimen that preferentially reduced recipient-retained GFP + KRMs decreased the cortical accumulation of RFP + cells, albuminuria, and histologic kidney injury in NTSN mice.
- 02Study Evidence
Tested in a in vivo animal model (preclinical discovery) at the preclinical stage.
- 03Practical Meaning
Early laboratory or animal model findings — human trials are still needed to confirm safety and benefit.
Biological Mechanism & Study Design
Study Design & Cohort
Animal models
In vivo animal model (Preclinical discovery) · Preclinical
Biological Pathway & Modality
Immune response
Intervention: Ontogenically distinct macrophages occupy discrete kidney niches and contribute to
Experimental Findings & Endpoints
To explore this, we used single-cell RNA sequencing (scRNA-seq), reporter-based bone marrow chimeras, timed clodronate liposome treatment, and chemokine blockade to define the spatiotemporal dynamics and functional roles of macrophage populations in nephrotoxic serum nephritis (NTSN), a model of cGN. scRNA-seq of total kidney and CD45 + immune cells revealed that proliferating macrophages and infiltrating monocytes expanded sharply by day five and declined by day ten, indicating that local proliferation, in addition to monocyte recruitment, contributes substantially to early macrophage accumulation in NTSN.
Two major KRM subpopulations were distinguished by high Ccr2 or Mrc1 expression, consistent with bone marrow and embryonically seeded, self-renewing KRM population, respectively. In Cx3cr1-GFP recipient mice reconstituted with Ccr2-RFP + donor bone marrow, embryonic-derived GFP + KRMs were enriched in the outer medulla and corticomedullary region, whereas donor-derived RFP + monocytes/macrophages preferentially accumulated in the cortex, including within and around the inflamed glomeruli.
A timed clodronate liposome regimen that preferentially reduced recipient-retained GFP + KRMs decreased the cortical accumulation of RFP + cells, albuminuria, and histologic kidney injury in NTSN mice. Cell-cell communication analysis identified macrophage-associated CCL12 expression, a murine ortholog of human CCL2, as a candidate mediator of cortical CCR2 + monocyte recruitment.
CCL12 neutralization reduced cortical monocyte accumulation and ameliorated kidney damage in NTSN mice.
Clinical Translation & Practice Context
These findings indicate that ontogenically distinct and spatially segregated macrophage populations cooperate during early cGN and support further investigation of the CCR2 axis as a therapeutic target for macrophage-mediated kidney injury in cGN.
The Bottom Line · Clinical Pearl
“These findings indicate that ontogenically distinct and spatially segregated macrophage populations cooperate during early cGN and support further investigation of the CCR2 axis as a therapeutic target for macrophage-mediated kidney injury in cGN.”
Published in Kidney International · Current Stage: Preclinical